中文产业新闻精选评分80Chinese source
武田OX2R激动剂Oveporexton获FDA批准用于成人1型发作性睡病
告别“秒睡” 与突发无力：全球首创靶向新药获FDA批准
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
告别“秒睡” 与突发无力：全球首创靶向新药获FDA批准
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.